Saint-Gély-du-Fesc, France

Tangui Maurice

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Anavex Life Sciences Corp.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tangui Maurice. Retrieved from https://idiyas.com/inventor/tangui-maurice-3zav96i4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tangui Maurice

Introduction

Tangui Maurice is a notable inventor based in Saint Gely du Fesc, France. He has made significant contributions to the field of neuroprotection through his innovative work. His research focuses on developing therapeutic solutions that can aid in the treatment of neurodegenerative conditions.

Latest Patents

Tangui Maurice holds a patent for ANAVEX2-73 and certain anticholinesterase inhibitors composition and method for neuroprotection. This invention involves a dosage form that comprises a therapeutically neuroprotective amount of A2-73 and a neuroprotective amount of at least one cooperating acetylcholinesterase inhibitor. The inhibitors selected for this composition include donepezil, galantamine, rivastigmine, or memantine. The method of use for this invention aims to provide effective neuroprotection.

Career Highlights

Tangui Maurice is associated with Anavex Life Sciences Corporation, where he continues to advance his research and development efforts. His work is pivotal in exploring new avenues for neuroprotective therapies.

Collaborations

He collaborates with Alexandre Vamvakides, contributing to the innovative projects at Anavex Life Sciences Corporation.

Conclusion

Tangui Maurice's contributions to neuroprotection through his patent and work at Anavex Life Sciences Corporation highlight his role as a significant inventor in the field. His innovative approaches are paving the way for advancements in therapeutic solutions for neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…